TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint InhibitorsScott T. Tagawa, Petros Grivas, Daniel P. Petrylak et al.|Journal of Clinical Oncology|2021Cited by 530
TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.Phillip L. Palmbos, Pierre A. Coulombe|Research Square|2023Cited by 2
TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesionYin Wang, Phillip L. Palmbos|Oncogene|2025Cited by 2